ES525667A0 - Un metodo para preparar una cepa de salmonella typhi atenuada, de galactosa, sin epimerasa - Google Patents

Un metodo para preparar una cepa de salmonella typhi atenuada, de galactosa, sin epimerasa

Info

Publication number
ES525667A0
ES525667A0 ES525667A ES525667A ES525667A0 ES 525667 A0 ES525667 A0 ES 525667A0 ES 525667 A ES525667 A ES 525667A ES 525667 A ES525667 A ES 525667A ES 525667 A0 ES525667 A0 ES 525667A0
Authority
ES
Spain
Prior art keywords
free
epimerase
salmonella
galactose
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES525667A
Other languages
English (en)
Other versions
ES8506191A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag GmbH International
Original Assignee
Schweiz Serum und Impfinstitut Bern
Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweiz Serum und Impfinstitut Bern, Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten filed Critical Schweiz Serum und Impfinstitut Bern
Publication of ES525667A0 publication Critical patent/ES525667A0/es
Publication of ES8506191A1 publication Critical patent/ES8506191A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
ES525667A 1981-07-31 1983-09-16 Un metodo para preparar una cepa de salmonella typhi atenuada, de galactosa, sin epimerasa Expired ES8506191A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/289,013 US4632830A (en) 1981-07-31 1981-07-31 Oral vaccine for immunization against enteric disease

Publications (2)

Publication Number Publication Date
ES525667A0 true ES525667A0 (es) 1985-07-01
ES8506191A1 ES8506191A1 (es) 1985-07-01

Family

ID=23109633

Family Applications (2)

Application Number Title Priority Date Filing Date
ES514617A Granted ES514617A0 (es) 1981-07-31 1982-07-31 "un procedimiento para preparar una vacuna oral para inmunizacion contra enfermedades entericas".
ES525667A Expired ES8506191A1 (es) 1981-07-31 1983-09-16 Un metodo para preparar una cepa de salmonella typhi atenuada, de galactosa, sin epimerasa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES514617A Granted ES514617A0 (es) 1981-07-31 1982-07-31 "un procedimiento para preparar una vacuna oral para inmunizacion contra enfermedades entericas".

Country Status (11)

Country Link
US (1) US4632830A (es)
EP (1) EP0088108B1 (es)
JP (1) JPS58501325A (es)
AU (1) AU564871B2 (es)
CA (1) CA1241917A (es)
DE (1) DE3276151D1 (es)
DK (1) DK145583A (es)
ES (2) ES514617A0 (es)
PT (1) PT75364B (es)
WO (1) WO1983000437A1 (es)
ZA (1) ZA825555B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
WO1985003521A1 (en) * 1984-02-01 1985-08-15 Enterovax Research Pty. Ltd. Bacterial strains
AU619908B2 (en) * 1984-02-01 1992-02-06 Enterovax Research Pty. Ltd. Bacterial strains
EP0249449A1 (en) * 1986-06-11 1987-12-16 Enterovax Research Pty. Ltd. Bacterial strain for live vaccines
US5110588A (en) * 1986-08-19 1992-05-05 Enterovax Limited Composite salmonella E. coli, Vibrio cholerae vaccine strains
US5112749A (en) * 1987-10-02 1992-05-12 Praxis Biologics, Inc. Vaccines for the malaria circumsporozoite protein
JPH0284172A (ja) * 1988-07-21 1990-03-26 Smithkline Beckman Corp 異種遺伝子の発現能を有し、組換え型ワクチンとして有用なサルモネラ形質転換体
KR930001382B1 (ko) * 1990-09-05 1993-02-27 보령신약 주식회사 경구용 장티프스 생균백신 및 그의 제조방법
DE4041045A1 (de) * 1990-12-20 1992-07-02 Max Planck Gesellschaft Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen
US5552144A (en) * 1992-01-22 1996-09-03 Microcarb, Inc. Immunogenic shiga-like toxin II variant mutants
SG46987A1 (en) * 1992-04-10 1998-03-20 Schweiz Serum & Impfinst Recombinant live vaccines
US5871751A (en) * 1994-10-12 1999-02-16 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Renibacterium salmoninarum vaccine and method for its preparation
US6254874B1 (en) 1995-04-13 2001-07-03 President And Fellows Of Harvard College Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same
IL123569A (en) * 1995-09-06 2006-10-05 Dept Of The Army Attenuated shigella strain for delivering a mamalian expression plasmid into a mammalian cell
US6020144A (en) * 1996-09-12 2000-02-01 Symbiontics, Inc. Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same
KR20020028547A (ko) * 2000-10-10 2002-04-17 우재영 경구용 장티푸스백신 장용코팅과립조성물 및 그의 제조방법
RU2241031C2 (ru) * 2001-11-20 2004-11-27 Сергеев Василий Васильевич Штамм бактерий shigella sonnei, фаза 1, стабильный продуцент s-липополисахарида
US7541043B2 (en) 2002-01-16 2009-06-02 The United States Of America As Represented By The Department Of Health And Human Services Vaccine for protection against Shigella sonnei disease
EP1670505B1 (en) 2003-09-18 2012-11-14 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Dna promoters and anthrax vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856935A (en) * 1971-04-29 1974-12-24 Schweiz Serum & Impfinst Oral typhoid vaccine and method of preparing the same
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes

Also Published As

Publication number Publication date
EP0088108A4 (en) 1983-12-01
AU564871B2 (en) 1987-08-27
ES8405275A1 (es) 1984-06-01
WO1983000437A1 (en) 1983-02-17
ES514617A0 (es) 1984-06-01
JPS58501325A (ja) 1983-08-11
ES8506191A1 (es) 1985-07-01
JPH0467953B2 (es) 1992-10-29
EP0088108B1 (en) 1987-04-29
PT75364B (fr) 1985-11-20
US4632830A (en) 1986-12-30
AU8907882A (en) 1983-02-22
CA1241917A (en) 1988-09-13
DK145583D0 (da) 1983-03-30
EP0088108A1 (en) 1983-09-14
DE3276151D1 (en) 1987-06-04
DK145583A (da) 1983-03-30
ZA825555B (en) 1983-06-29
PT75364A (fr) 1982-09-01

Similar Documents

Publication Publication Date Title
ES525667A0 (es) Un metodo para preparar una cepa de salmonella typhi atenuada, de galactosa, sin epimerasa
ES502607A0 (es) Una instalacion para preparar alimentos.
ES515182A0 (es) Metodo para fijar una valvula de corazon.
ES511741A0 (es) Un metodo para producir un polipeptido.
ES544638A0 (es) Un metodo para preparar un extracto capaz de inmunizar a los pollos contra la occidiosis.
ES505841A0 (es) Un sistema de control para una turbina de vapor
ES516866A0 (es) Un procedimiento para preparar nuevos compuestos peptidicos.
ES506992A0 (es) Un procedimiento para la preparacion de una macroliada.
AR231998A1 (es) Procedimiento para preparar una cepa mejorada de clostridium acetobutylicum
ES524698A0 (es) Un procedimiento para preparar una beta-lactama.
ES513296A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES530392A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES511789A0 (es) Un metodo para la preparacion de un tejido natural fijado para implantacion con una mejor resistencia a la mineralizacion.
ES492315A0 (es) Un metodo para la preparacionde una emulsion acuosa de sili-cona.
ES521047A0 (es) Un procedimiento para preparar compuestos de cefem.
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES538192A0 (es) Un procedimiento para preparar un 2-bromo-6b-9a - difluoro-11b, 17a, 21-trihidroxi-1, 4-pregnadien-3, 20-diona-17, 21-diester
ES507065A0 (es) Un metodo para preparar derivados de 2-oxoazetidina.
ES522585A0 (es) Un metodo para determinar la presencia de una neoplasia.
ES521361A0 (es) Un metodo para preparar un derivado 14-acilico de lankacidina.
ES505393A0 (es) Un metodo para formar una composicion explosiva permisible.
ES521049A0 (es) Un metodo para fabricar aldehidos.
ES531067A0 (es) Un metodo para preparar una composicion agricolamente eficaz
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES518972A0 (es) Un procedimiento para la preparacion de pirbuterol.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000201